-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – NRC-2694 in Oropharyngeal Cancer
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.NRC-2694 in Oropharyngeal Cancer Drug Details:NRC-2694 is under development for the treatment of recurrent head and...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – NRC-2694 in Laryngeal Cancer
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data.NRC-2694 in Laryngeal CancerDrug Details:NRC-2694 is under development for the treatment of recurrent head and neck...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – NRC-2694 in Hypopharyngeal Cancer
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data.NRC-2694 in Hypopharyngeal CancerDrug Details:NRC-2694 is under development for the treatment of recurrent head and neck...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – NRC-2694 in Oral Cavity (Mouth) Cancer
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data.NRC-2694 in Oral Cavity (Mouth) CancerDrug Details:NRC-2694 is under development for the treatment of recurrent head...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – NRC-2694 in Recurrent Head And Neck Cancer Squamous Cell Carcinoma
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.NRC-2694 in Recurrent Head And Neck Cancer Squamous Cell Carcinoma Drug Details:NRC-2694 is under development for...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – AK-127 in Solid Tumor
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. AK-127 in Solid Tumor Drug Details: AK-127 is under development for the treatment of...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – OXI-4503 in Relapsed Acute Myeloid Leukemia
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.OXI-4503 in Relapsed Acute Myeloid Leukemia Drug Details:OXI-4503 (combretastatin A1 di-phosphate / CA1P) is under development...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – BI-907828 in Leiomyosarcoma
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. BI-907828 in Leiomyosarcoma Drug Details: BI-907828 is under development for the treatment of solid...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – MRNA-1083 in Influenzavirus B Infections
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data.MRNA-1083 in Influenzavirus B InfectionsDrug Details:mRNA-1083 is under development for the prevention of influenza virus infection...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Ligufalimab in Non-Hodgkin Lymphoma
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Ligufalimab in Non-Hodgkin Lymphoma Drug Details: Ligufalimab is under development for the treatment of...
-
Company Profile
![]()
National Research Corp – Company Profile
National Research Corp (NRC Health) is a healthcare organization that provides market insight solutions. The company solutions include experience collection, loyalty and retention, market insights, transparency of experience data and governance. It offers market insights solutions that allow the tracking of awareness, perception and consistency of healthcare brands, assessment of competitive differentiators and enhanced segmentation tools. NRC Health also provides experience solutions, such as patient and resident experience, workforce engagement, health risk assessments, transitions and improvement tools and marketing. The...
Add to Basket -
Product Insights
Therapeutic Monitoring Systems Inc. (TMS) Pipeline Insight and Competitive Landscape, 2023
Therapeutic Monitoring Systems Inc. (TMS) is a healthcare informatics company developing innovative clinical decision support software to improve patient outcomes in critical care medicine. It was founded by Andrew Seely. <br><br> TMS' CIMVA (continuous individualized multiorgan variability analysis) family of software applications continuously analyzes patient vital sign variability in order to detect changes in patient health status not otherwise observable using current standard-of-care monitoring in the ICU. CIMVA holds the promise of significantly improving the diagnosis, prognosis and treatment of...
-
Product Insights
![]()
Likelihood of Approval and Phase Transition Success Rate Model – NRC-2694
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry NRC-2694 Drug Details NRC-2694 is under development for the treatment of recurrent head and...
-
Product Insights
NRC – Rehabilitation of Minna-Baro Railway Line – Niger
Equip yourself with the essential tools needed to make informed and profitable decisions with our NRC - Rehabilitation of Minna-Baro Railway Line - Niger report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full story: Dive deep into...
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.